Rabbit Recombinant Monoclonal Glycoprotein G antibody. Suitable for WB, I-ELISA and reacts with Transfected cell lysate - Nipah virus, Recombinant fragment - Nipah virus samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | I-ELISA | |
---|---|---|
Nipah virus | Predicted | Predicted |
Recombinant fragment - Nipah virus | Not recommended | Tested |
Transfected cell lysate - Nipah virus | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Nipah virus | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Nipah virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Nipah virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Nipah virus | Dilution info 1000 ng/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Nipah virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Nipah virus | Dilution info - | Notes - |
Interacts with host ephrinB2/EFNB2 or ephrin B3/EFNB3 to provide virion attachment to target cell. This attachment induces virion internalization predominantly through clathrin-mediated endocytosis.
Glycoprotein G, G
Rabbit Recombinant Monoclonal Glycoprotein G antibody. Suitable for WB, I-ELISA and reacts with Transfected cell lysate - Nipah virus, Recombinant fragment - Nipah virus samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Nipah virus Glycoprotein G also known as NiV-G serves mechanically as an essential viral attachment protein. This glycoprotein with a mass of approximately 70 kDa is expressed on the surface of the Nipah virus envelope. It facilitates viral entry into host cells by binding to ephrin-B2 and ephrin-B3 receptors. Its activity is necessary for initiating infection in host species including humans and animals.
Glycoproteins like Nipah virus Glycoprotein G play a significant role in viral life cycles. NiV-G exists as a part of a complex and works in conjunction with other viral proteins especially the fusion protein F to mediate membrane fusion. By binding selectively to host cell receptors it determines the host range and tissue tropism of the virus. The interaction with host receptors also impacts the viral spread within the host organism.
Several viral entry mechanisms involve Nipah virus Glycoprotein G. The fusion process involving this glycoprotein and the fusion protein (F protein) is a part of the cell entry pathway. This pathway is critical for the virus to access intracellular machinery. Additionally NiV-G is connected with signaling pathways through its interaction with ephrin receptors contributing to viral pathogenesis and immune evasion.
Nipah virus Glycoprotein G is significantly associated with Nipah virus infection leading to severe encephalitis and respiratory illness. This protein through its interaction with ephrin-B2 and ephrin-B3 contributes to the virus's ability to cause widespread cell damage in the brain and respiratory tissues. Moreover the glycoprotein F works in concert with NiV-G to facilitate transmission and heightened virulence of the infection highlighting the critical role of these proteins in disease progression.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Indirect ELISA analysis of ab322205 at 1000-0 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1:2500 dilution.
Antigen: Nipah virus Glycoprotein G.
Antigen concentration: 1000 ng/ml
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
This antibody does not cross-react with Hendra virus Glycoprotein G.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (Anti-6X His tag® antibody [EPR20547] - ChIP Grade ab213204) staining at 1/5000 dilution.
All lanes: Western blot - Anti-Nipah virus Glycoprotein G antibody [EPR29883-707] (ab322205) at 1/1000 dilution
Lane 1: 293T cells transfected with an empty vector containing a myc-his tag, whole cell lysate at 20 µg
Lane 2: 293T cells transfected with a Nipah virus Glycoprotein G expression vector containing a myc-his-tag, whole cell lysate at 20 µg
Lane 3: 293T cells transfected with a Hendra virus Glycoprotein G expression vector containing a myc-his-tag, whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 75 kDa, 36 kDa
Exposure time: 3s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com